Noel Maestre, advanced therapy medicinal product (ATMP) director at CRB guides readers through the steps needed to implement manufacturing strategies for advanced medicines.
As the manufacture of biologics takes on increased significance in the pharmaceutical sector, it’s clear to see why GE Healthcare’s KUBio system is growing in popularity. Lu Rahman paid a visit to the company facility in Uppsala to find out more…
Supplier to the pharma, biotech and specialty ingredients markets, Lonza, has expanded its late-stage clinical and commercial encapsulation capabilities for solid oral and inhaled dosage forms in the US.
Accord Healthcare, a generic pharmaceutical company, has opened a new facility in Fawdon, Newcastle, expanding its portfolio to four sites situated within the UK.
Neil Pullman, principal architect at, Boulting Environmental Services, explores the differences between BIM Levels, their benefits and what it means for the pharmaceutical sector.
Indivior, a speciality pharmaceutical company, has opened a $30 million research and development (R&D) centre in Hull, UK, to further advance its treatment innovation into the global addiction crisis.
Contract development and manufacturing organisation (CDMO) that specialises in spray drying and capsule filling services, Micro-Sphere, is investing €19 million to expand its GMP manufacturing capabilities at its Swiss facility.
GlaxoSmithKline (GSK) has made several announcements regarding its forthcoming plans to improve the efficiency and competitiveness of its manufacturing network.
